EXCLUSIVE: Virax Biolabs Tells Benzinga 'The RT PCR Mpox virus detection kits are CE-marked for sale in Europe and also authorized by the Medicines and Healthcare products Regulatory Agency (MHRA), the product regulatory agency for the United Kingdom'
Portfolio Pulse from Benzinga Newsdesk
Virax Biolabs has announced that its RT PCR Mpox virus detection kits are CE-marked for sale in Europe and authorized by the UK's MHRA, indicating regulatory approval for these markets.
August 28, 2024 | 11:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Virax Biolabs' RT PCR Mpox virus detection kits have received CE-marking and MHRA authorization, allowing sales in Europe and the UK. This regulatory approval could enhance market access and sales potential for the company.
The CE-mark and MHRA authorization are significant regulatory milestones that enable Virax Biolabs to sell its RT PCR Mpox virus detection kits in Europe and the UK. This could lead to increased sales and market presence, positively impacting the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100